Compare Stocks

→ Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CRW 506692 (CRW.TO)		C$0.00	C$0.00 ▼ C$0.40	N/A	N/A	32,717 shs	N/A
DOC Healthpeak Properties	$18.70 +2.0%	$16.52	$15.24 ▼ $22.38	$13.27B	1.02	7.21 million shs	1.90 million shs
FORA Forian	$2.71 -0.4%	$2.97	$1.85 ▼ $4.15	$84.37M	1.03	26,091 shs	4,579 shs
SENS Senseonics	$0.43 +1.7%	$0.56	$0.38 ▼ $1.05	$225.81M	0.87	2.43 million shs	391,027 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DOC Healthpeak Properties	-1.58%	+1.83%	+4.44%	+42.78%	+31.00%
FORA Forian	+4.62%	+10.57%	-16.56%	+1.49%	-3.55%
SENS Senseonics	-3.70%	+0.24%	-24.86%	-21.32%	-29.06%

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CRW 506692 (CRW.TO)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DOC Healthpeak Properties	3.9205 of 5 stars	1.3	4.0	2.5	3.7	2.6	1.7	1.9
FORA Forian	1.9658 of 5 stars	3.5	2.0	0.0	0.0	0.9	1.7	1.3
SENS Senseonics	0.4298 of 5 stars	3.0	0.0	0.0	0.0	0.0	0.0	0.6

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CRW 506692 (CRW.TO)	N/A	N/A	N/A	N/A
DOC Healthpeak Properties	2.50	Moderate Buy	$18.10	-3.21% Downside
FORA Forian	3.00	Buy	$7.67	182.90% Upside
SENS Senseonics	2.00	Hold	$1.25	193.84% Upside

Current Analyst Ratings

Latest DOC, FORA, SENS, and CRW Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/22/2024	DOC Healthpeak Properties	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy	$22.00
4/10/2024	DOC Healthpeak Properties	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$21.00 ➝ $22.00
4/4/2024	FORA Forian	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00
4/1/2024	DOC Healthpeak Properties	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underperform ➝ Buy	$18.00 ➝ $25.00
3/25/2024	DOC Healthpeak Properties	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Equal Weight	$19.00
3/8/2024	DOC Healthpeak Properties	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$21.00

(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CRW 506692 (CRW.TO)	N/A	N/A	N/A	N/A	N/A	N/A
DOC Healthpeak Properties	$2.18B	6.08	$1.76 per share	10.65	$12.57 per share	1.49
FORA Forian	$20.48M	4.12	N/A	N/A	N/A	∞
SENS Senseonics	$22.39M	10.09	N/A	N/A	$0.07 per share	6.08

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CRW 506692 (CRW.TO)	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
DOC Healthpeak Properties	$306.01M	$0.56	33.39	10.00	1.84	13.97%	4.34%	1.95%	7/25/2024 (Estimated)
FORA Forian	N/A	$0.33	8.21	∞	N/A	N/A	N/A	N/A	5/10/2024 (Estimated)
SENS Senseonics	-$60.39M	-$0.11	N/A	N/A	N/A	-270.13%	-146.90%	-49.81%	N/A

Latest DOC, FORA, SENS, and CRW Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/28/2024	Q4 2023	FORA Forian	N/A	-$0.01	-$0.01	-$0.06	$5.72 million	$5.37 million
2/29/2024	Q4 2023	SENS Senseonics	-$0.04	-$0.03	+$0.01	-$0.03	$7.62 million	$8.00 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CRW 506692 (CRW.TO)	N/A	N/A	N/A	N/A	N/A
DOC Healthpeak Properties	$1.20	6.42%	N/A	214.29%	N/A
FORA Forian	N/A	N/A	N/A	N/A	N/A
SENS Senseonics	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CRW 506692 (CRW.TO)	N/A	N/A	N/A
DOC Healthpeak Properties	1.00	0.67	0.67
FORA Forian	N/A	N/A	N/A
SENS Senseonics	1.15	7.53	7.03

Ownership

Institutional Ownership

Company	Institutional Ownership
CRW 506692 (CRW.TO)	N/A
DOC Healthpeak Properties	93.57%
FORA Forian	19.25%
SENS Senseonics	12.36%

Insider Ownership

Company	Insider Ownership
CRW 506692 (CRW.TO)	N/A
DOC Healthpeak Properties	0.30%
FORA Forian	31.30%
SENS Senseonics	3.90%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CRW 506692 (CRW.TO)	147,000	N/A	N/A	Not Optionable
DOC Healthpeak Properties	193	709.58 million	707.45 million	Optionable
FORA Forian	102	31.13 million	N/A	Optionable
SENS Senseonics	132	530.82 million	510.12 million	N/A

DOC, FORA, SENS, and CRW Headlines

Source	Headline
	Senseonics (NYSE:SENS) Trading Up 7.8% americanbankingnews.com - April 24 at 3:00 AM
	Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies 2024 finance.yahoo.com - April 4 at 8:15 AM
	Comprehensive Market Analysis Reveals Significant Insights into the Insulin Pumps and Continuous Glucose Monitors Market Through 2033 finance.yahoo.com - April 3 at 3:17 PM
	Senseonics (NYSE:SENS) Lifted to Sell at StockNews.com marketbeat.com - March 29 at 11:14 PM
	Professional Wearable Medical Device Market: Driving Innovations in Healthcare Technology pharmiweb.com - March 15 at 9:00 AM
	Ascensia, Senseonics announce new CGM cost savings massdevice.com - March 12 at 3:02 PM
	Experts Offer CGM Tips for Type 1 Diabetes medscape.com - March 12 at 7:47 AM
	SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS prnewswire.com - March 12 at 7:00 AM
	Hand Held Glucose Meter Market – Navigating Trends and Transformations in Glucose Monitoring pharmiweb.com - March 11 at 5:22 AM
	Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes businesswire.com - March 8 at 8:05 AM
	Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference businesswire.com - March 6 at 8:05 AM
	Senseonics Holdings, Inc. (AMEX:SENS) Q4 2023 Earnings Call Transcript finance.yahoo.com - March 2 at 9:13 AM
	Senseonics slips amid concerns over demand for Eversense msn.com - March 1 at 7:41 AM
	Q4 2023 Senseonics Holdings Inc Earnings Call finance.yahoo.com - March 1 at 7:41 AM
	Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue Estimates zacks.com - February 29 at 7:31 PM
	Senseonics GAAP EPS of -$0.03 beats by $0.01, revenue of $8M beats by $0.38M msn.com - February 29 at 5:58 PM
	FDA submission for 365-day CGM from Senseonics is ‘imminent’ massdevice.com - February 29 at 5:58 PM
	Senseonics: Q4 Earnings Snapshot washingtonpost.com - February 29 at 5:58 PM
	Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results finance.yahoo.com - February 29 at 4:23 PM
	Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results businesswire.com - February 29 at 4:05 PM
	Here's what to expect from Senseonics's earnings markets.businessinsider.com - February 28 at 10:14 AM
	SENS Jan 2026 1.500 put finance.yahoo.com - February 25 at 10:57 PM
	Senseonics Holdings Stock (AMEX:SENS), Short Interest Report benzinga.com - February 22 at 10:43 PM
	SENS Mar 2024 0.500 call ca.finance.yahoo.com - February 21 at 12:06 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Alphabet and Microsoft push Wall Street toward its first winning week in a month
April 26, 2024 3:21 AM
View Stock market today: Alphabet and Microsoft push Wall Street toward its first winning week in a month
Lockheed Martin Stock Aims for a Fresh All-Time High
April 23, 2024 9:59 AM
View Lockheed Martin Stock Aims for a Fresh All-Time High
DocuSign and The Case for 66% Upside
April 16, 2024 10:20 AM
View DocuSign and The Case for 66% Upside
D.R. Horton Stock Has Tailwinds To Drive it Higher
April 18, 2024 8:30 AM
View D.R. Horton Stock Has Tailwinds To Drive it Higher

All Headlines

Company Descriptions

506692 (CRW.TO)

TSE:CRW

Healthpeak Properties

NYSE:DOC

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Forian

NASDAQ:FORA

Forian Inc. provides software and information solutions, proprietary data driven insights, and predictive analytics to optimize and measure the operational, clinical, and financial performance of its life science and healthcare customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides customers with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; and BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain. In addition, the company offers security monitoring and web marketing services. Forian Inc. was incorporated in 2020 and is headquartered in Newtown, Pennsylvania. Forian Inc.

Senseonics

NYSE:SENS

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial